Member Info for Fastfood

I’d like to think Ken Roberts will now be wanting to take the Ciz blood Test every 6 to 12 months at his local GP.

25 May 2026

“Thousands of people in England have had lung cancer caught early thanks to NHS scanning trucks in supermarket car parks, sports stadiums and busy high streets.

New NHS data shows 10,678 lung cancers have been detected through the programme since it began – more than three quarters of which were caught at stages one or two.

People diagnosed with lung cancer at the earliest stages are nearly 13 times more likely to survive for five years than those whose cancer is caught late.

Local health teams perform in-depth lung health checks and scans on current and past smokers aged 55-74 years old.

The trucks form part of the NHS Lung Cancer Screening Programme – launched in 2019 in the areas hardest hit by the disease – which has now reached half of England’s most at-risk people.

One person who benefitted from an earlier cancer diagnosis through the NHS Lung Cancer Screening Programme is Ken Roberts, a 74 years-old manufacturing company director from Ladybridge, Bolton.

Ken was invited for a lung health check when a mobile scanning unit was parked at Morrisons in Bolton.

The granddad-of-five had no symptoms, so initially thought he wouldn’t go, but changed his mind. A few days later Ken was asked to go for a further scan in hospital, and after some more checks was told he had stage 1 lung cancer. Ken underwent surgery, and, thanks to his early cancer detection, no further treatment was needed.

Ken said: “I ummed and ahhed about whether to go, but in the end, I went because it was so convenient, and I could park really easily!

“I answered the health questions with a nurse and then they offered me a scan on the truck that same day which I had too.

“They explained what would happen next and what the options were. I went to Oldham for a positron emission tomography scan and then to Wythenshawe Hospital for a biopsy. This confirmed it was lung cancer, but it had been found at an early stage – stage 1 – and was treatable with surgery.

“I opted to have robotic-assisted thoracoscopic surgery, and I feel incredibly positive about my outcome because the cancer was found so early.

“Now I just feel really lucky that I went for that lung health check as I so nearly didn’t go. And I’m telling everyone to go for theirs when they get the invite.

“It’s really good news that thousands of people in Greater Manchester and across England have had their lung cancer diagnosed by this NHS scheme. This enables people to start treatment sooner, which makes it much more likely it will be successful.

“Without this scheme many of us – like me – wouldn’t have known we had lung cancer and got help for it.”

Under the new National Cancer Plan, the Government is aiming for 75% of people diagnosed with cancer to survive for five years or more by 2035. National rollout of lung cancer screening throughout England is a key part of this.

The nationwide rollout of the NHS’s programme by 2030 will lead to over 6 million people across

Opening up Strait of Hormuz tied into the World Cup (funnily enough - coincidence) will help. See what SP does. Blockade could well return after World Cup so buy now and sell a few during Semi Final.

Although I am only accumulating here for next 5 years. Kaboom.

It may seem trivial but the lower the SP goes, say below £5 / The higher the amount of Shares can be purchased and cancelled. Thus positively effecting the SP based on Market Capitalisation.

Located on Blackfriars Rd. Just one Tube stop from the Shard.

Our state-of-the-art hub laboratory in Blackfriars Road, London, is at the heart of our programme to deliver and transform pathology services in south east London.

One of the largest, purpose-built pathology laboratories in the UK, this world-class facility is filled with cutting-edge technology and will process around 70 per cent of all pathology activity conducted by Synnovis, serving a patient population of almost two million.

Spanning 10 floors flooded by natural light, the hub has been designed to meet the needs of modern-day healthcare services, delivering major benefits for clinicians, patients, those who work there and the NHS overall.

Once completed, the hub will house the majority of south east London’s infection, tissue and blood sciences, as well as reference chemistry and specialist services such as toxicology and immunology.

“Through cutting-edge digital pathology technology, clinicians will be able to view blood and tissue samples remotely via high-resolution monitors and without the need for microscopes, increasing efficiency and speeding up patient diagnosis.”

State-of-the-art.

“.. acting in partnership with the NHS. The LOI covers the verification and validation of the Company's CIZ1B biomarker test with a NHS Foundation Trust partner in state-of-the-art laboratories which may lead to the Provider being appointed as the Company's exclusive UK supplier of the CIZ1B test.”

Great work ThinShins. You could be right.

I don’t think we will get Accreditation Green light before AGM. Hence the fact they’ve probably brought it forward. But I could be wrong.

Enjoy Bermondsey I hope you have a good time and leave with a positive feeling about the future of the business.

Sorry Typo.

AGM to be held 16/6/26 this year vs 30/6/25 last year.

Cannot have the CLIA conflicting with AGM.

Same 3 1/2 week Notice period for Announcement to AGM vs last year.

AGM 2025 was held 30/6/25 last year.

AGM to be held 14/6/26 this year.

For me / I think they will have planned to get AGM out of the way before CLIA accreditation News expected to follow in the 2 weeks thereafter. Still within Q2. They will know the date. It’s not like they’re ringing them up daily is it ?

Aiden. I once had a Share that went from 3p to 27p in 2 days on No News No RNS and to this day never had finished product available to Market. So there is hope.

I see this as a One Trick pony. No diversification. No other Focus. As Hogbog says / Company run by 5 people / Key people that is / and all over 60. The RNS re Options was best News you could have had considering.

I wish you well in re break even and there is more hope now than recent years definitely. This could be the one.

Also Hogbog. I’m pretty sure Cizzle bought out Bould Opportunities 2021. Since then and based on nothing more than a hunch - I imagined their Timeline to be 7 Years / which takes us to 2028. That’s my Timeline for full realisation of Value and I’m not Selling for no one until 2028. I think Cizz paid £20/£21m back in 2021 for the technology. Since then we’ve had World hyper inflation due to Pandemic and many Asset prices have doubled. Back then the product had no route to Market and no actual developed Test.

On the brink.

Hogbog. Allan is defo 69/70.

And in response to Lovelyboy previous post on the 10 year Option Timeline. One reason for the 10 year may be to give the Directors Maximum time to Not cash in that First Tranche at 2p as it’s those that potentially make gigantism profit if they cash in above say 15p. You would give yourself maximum time wouldn’t you ? A Timeline way beyond any Business Plan.

The 10 years imo is simply aligned to maximum flexibility re Extraction of Value / rather than aligned to any Long Term plan for the Business. It may take 10 years. But it also may take less than 5.

Just my opinion.

A discussion required on here as to why imo the Strike Price were set so high (Apart from 2p). For example : No one would have blinked an eye if Strike price was set 2/3/6/9p. I guess it’s a Question of what the Market can absorb and based on current long term low volume history / then perhaps this is one reason why the 10p and 15p were set ?

It doesn’t make complete sense to me to set the last 2 Milestone Stroke price so high as the Directors are foregoing potential profit / when my example of 6p and 9p potentially acceptable to the Market ?

I for one am staying in. Could get 3.5p for 1.25m. Usually Max quote limited to 500k. On odd occasion 800k.

The 400.000 Sales at 2pm and later undisclosed were Sells because just after 2pm I could Sell 500.000 max and price was 3.31. Of course I didn’t Sell though. No chance.

Checkout the last sentance.

Q4: How does this UK partnership complement Cizzle Biotechnology’s existing licensing agreement that you do have in North America and support its broader global expansion strategy?

A: I said very early on in the interview that we are a business that’s developed fantastic technology in terms of the Cizzle biomarker, but it requires partnerships to make that globally available to anybody that wants to benefit from the test. That means, therefore, working with expert clinical groups around the world.

We chose the United States as the first target simply because they have a well-established means within their laboratory set up across the States to provide so-called laboratory developed tests early to patients. That was a licensing arrangement that we set up, it generates for Cizzle, a royalty income, and in the United States, it’s an exclusive deal, which means that we get guaranteed royalties for the first $2.4 million, of which we’ve already received over $500,000 of that. So that’s been very valuable to the business.

We want to roll out similar models elsewhere in the world. As I said early on, it’s very important for us to bring the technology to bear here in its birthplace back in the United Kingdom and ensure that people here in the UK benefit from the support that the research councils and particularly Yorkshire Cancer Research provided in the very early days of getting this test from its origins in the research lab to become a commercial test.

So, it’s a similar arrangement, it will be the similar verification process, it will be the similar deal that we are seeking to partner with somebody that has broad access across the United Kingdom. Hopefully, we’ll be able to roll that out elsewhere in Europe and then onwards throughout the world.

These are very parallel relationships. It’s very much the same type of validation process,

I wonder if they are banking up the CLIA accreditation to late Q2 to allow the UK NHS to use the USA data to best effect ?

Worth a re read. Plenty of Newsflow to come 2026.

Q3: Just going into a bit more detail, though. What steps will be involved in the validation and commercialisation process of the CIZ1B biomarkers under this agreement?

A3: Well, the good news is we’ve already started. So, we announced our Letter of Intent and we’ve begun the process immediately with a laboratory in the UK. That requires a, if you like, verification and a validation process. We have to replicate in those labs exactly the same type of results as we get in the research labs at the University of York, and for that matter, the same as the commercial laboratories are doing in the United States.

That means the test has to be reliable, has to give the same result each day, it has to be reproducible. We have to determine that in a more commercial laboratory setting, that the test is going to give the right result each time it’s being used. That process has begun; it’s a validation and a verification process that will take some weeks to complete.